Research progress on the role of ferroptosis in the treatment of tumors

doi:10.16352/j.issn.1001-6325.2022.11.1781

Abstract

Abstract: Ferroptosis, as a regulated and non-apoptotic form of cell death, provides a new research direction for tumor therapy. Ferroptosis is involved in the development of drug resistance in some tumors and also in the treatment process of many tumor therapies, which is a neglected mechanism in tumor therapy. This article will introduce the relationship between ferroptosis and different tumor treatment therapies from the aspects of tumor chemotherapy, tumor radiation therapy and tumor immunotherapy, and summarize the strategies of improving tumor treatment effect by ferroptosis, in order to provide reference for tumor treatment.

Key words: ferroptosis, cell death, tumor

CLC Number:

WANG Feng-yu, LI Gen, LIN Xiao-yi, YAO Xin-yue, CHEN Yu. Research progress on the role of ferroptosis in the treatment of tumors[J]. Basic & Clinical Medicine, 2022, 42(11): 1781-1784.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2022.11.1781

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2022/V42/I11/1781

References 21

[1]	Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death[J]. Cell, 2012, 149: 1060-1072.
[2]	Yang WS, SriRamaratnam R, Welsch ME, et al. Regulation of ferroptotic cancer cell death by GPX4[J]. Cell, 2014, 156:317-331.
[3]	姜学东,李文雅.Erastin诱导人非小细胞肺癌细胞系A549凋亡[J].基础医学与临床,2021,41:1313-1317.
[4]	Song Z, Xiang X, Li J, et al. Ruscogenin induces ferroptosis in pancreatic cancer cells[J]. Oncol Rep, 2020, 43:516-524.
[5]	Guan Z, Chen J, Li X, et al. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation[J]. Biosci Rep, 2020, 40: BSR20201807. doi:10.1042/BSR20201807.
[6]	Yuan B, Liao F, Shi ZZ, et al. Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2/SLC7A11 Axis[J]. Onco Targets Ther, 2020, 13: 10829-10840.
[7]	Liu G, Kuang S, Cao R, et al. Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids via the ATP-AMPK-mTOR-SREBP1 signaling pathway[J]. FASEB J, 2019, 33: 10089-10103.
[8]	Li Y, Yan H, Xu X, et al. Erastin/sorafenib induces cisplatin-resistant non-small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway[J]. Oncol Lett, 2020, 19: 323-333.
[9]	Sehm T, Fan Z, Ghoochani A, et al. Sulfasalazine impacts on ferroptotic cell death and alleviates the tumor microenvironment and glioma-induced brain edema[J]. Oncotarget, 2016, 7: 36021-36033.
[10]	Li M, Chen X, Wang X, et al. RSL3 enhances the antitumor effect of cisplatin on prostate cancer cells via causing glycolysis dysfunction[J]. Biochem Pharmacol, 2021, 192: 114741. doi:10.1016/j.bcp.2021.114741.
[11]	Jiang Z, Lim SO, Yan M, et al. TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis[J]. J Clin Invest, 2021, 131:e139434. doi:10.1172/JCI139434.
[12]	Wang W, Green M, Choi JE, et al. CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy[J]. Nature, 2019, 569: 270-274.
[13]	Jiang Q, Wang K, Zhang X, et al. Platelet membrane-camouflaged magnetic nanoparticles for ferroptosis-enhanced cancer immunotherapy[J]. Small, 2020, 16: e2001704. doi:10.1002/smll.202001704.
[14]	Ping Z, Peng Y, Lang H, et al. Oxidative stress in radiation-induced cardiotoxicity[J]. Oxid Med Cell Longev, 2020, 2020: 1-15.
[15]	Lang X, Green MD, Wang W, et al. Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11[J]. Cancer Discov, 2019, 9: 1673-1685.
[16]	Ye LF, Chaudhary KR, Zandkarimi F, et al. Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers[J]. ACS Chem Biol, 2020, 15: 469-484.
[17]	Li X, Zhuang X, Qiao T. Role of ferroptosis in the process of acute radiation-induced lung injury in mice[J]. Biochem Biophys Res Commun, 2019,519: 240-245.
[18]	Shibata Y, Yasui H, Higashikawa K, et al. Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo[J]. PLoS One, 2019;14:e0225931. doi:10.1371/journal.pone.0225931.
[19]	Zhang Y, Tan H, Daniels JD, et al. Imidazole ketone erastin induces ferroptosis and slows tumor growth in a mouse lymphoma model[J]. Cell Chem Biol, 2019, 26: 623-633.
[20]	Klein S, Wegmann M, Distel LVR, et al. APTES-Terminated ultrasmall and iron-doped silicon nanoparticles as X-Ray dose enhancer for radiation therapy[J]. Biophys Res Commun, 2018, 498: 855-861.
[21]	Wan X, Song L, Pan W, et al. Tumor-targeted cascade nanoreactor based on metal-organic frameworks for synergistic ferroptosis-starvation anticancer therapy[J].ACS Nano, 2020, 14: 11017-11028.